Cel
Neurodegenerative (ND) and neuromuscular (NM) disease is one of the most frequent classes of rare diseases, affecting life and mobility of 500,000 patients in Europe and millions of their caregivers, family members and employers. This NEUROMICS project brings together the leading research groups in Europe, five highly innovative SMEs and relevant oversea experts using the most sophisticated Omics technologies to revolutionize diagnostics and to develop pathomechanism-based treatment for ten major ND and NM diseases. Specifically we aim to:
(i) use next generation WES to increase the number of known gene loci for the most heterogeneous disease groups from about 50% to 80%,
(ii) increase patient cohorts by large scale genotyping by enriched gene variant panels and NGS of so far unclassified patients and subsequent phenotyping,
(iii) develop biomarkers for clinical application with a strong emphasis on presymptomatic utility and cohort stratification,
(iv) combine -omics approaches to better understand pathophysiology and identify therapeutic targets,
(v) identify disease modifiers in disease subgroups cohorts with extreme age of onset
(vi) develop targeted therapies (to groups or personalized) using antisense oligos and histone deacetylase inhibitors, translating the consortiums expertise in clinical development from ongoing trials toward other disease groups, notably the PolyQ diseases and other NMD.
To warrant that advances affect a large fraction of patients we limited the selection to a number of major categories, some of which are in a promising stage of etiological and therapeutic research while some others are in great need of further classification. The efforts will be connected through a NEUROMICS platform for impact, communication and innovation that will provide tools and procedures for ensuring trial-readiness, WP performance, sustainability, interaction with the chosen Support IRDiRC and RD-Connect project and involvement of stakeholders in the NDD/NMD field.
Zaproszenie do składania wniosków
FP7-HEALTH-2012-INNOVATION-1
Zobacz inne projekty w ramach tego zaproszenia
System finansowania
CP-IP - Large-scale integrating projectKoordynator
72074 Tuebingen
Niemcy
Zobacz na mapie
Uczestnicy (18)
2333 ZA Leiden
Zobacz na mapie
50937 Koeln
Zobacz na mapie
NE1 7RU Newcastle Upon Tyne
Zobacz na mapie
53127 Bonn
Zobacz na mapie
WC1E 6BT London
Zobacz na mapie
13284 Marseille
Zobacz na mapie
75654 Paris
Zobacz na mapie
9052 ZWIJNAARDE - GENT
Zobacz na mapie
20122 Milano
Zobacz na mapie
44121 Ferrara
Zobacz na mapie
CB2 1TN Cambridge
Zobacz na mapie
101 Reykjavik
Zobacz na mapie
20850 ROCKVILLE
Zobacz na mapie
92100 BOULOGNE BILLANCOURT
Zobacz na mapie
SE16494 KISTA
Zobacz na mapie
6511 AA Nijmegen
Zobacz na mapie
6009 Crawley
Zobacz na mapie
79106 Freiburg
Zobacz na mapie